Promethera's Cell Therapy Attracts Corporate VCs To Largest European Biopharma Funding Round This Year
Belgium's Promethera raises $31.4 million to start clinical trials of its cell therapy for orphan liver diseases in a Series B funding
Belgium's Promethera raises $31.4 million to start clinical trials of its cell therapy for orphan liver diseases in a Series B funding